Submission Categories

 

RESEARCH: In-depth observational or experimental research.

  • Abstract: All research articles should have a structured abstract not exceeding 250 words and the following 5  headings: Background, Objectives, Patients and/or Methods, Results, and Conclusions.
  • Word count:  3,000 words or less excluding the abstract, references, figures, and tables. 
  • Key words: 5 key words must be provided. Case reports cannot be submitted as research articles.

REVIEW: Dermatology Practical & Conceptual welcomes narrative-historical and systematic reviews including meta-analyses. Authors are free to select more attractive headings for these narrative-historical reviews.

  • Abstract: A structured abstract not exceeding 250 words must include the 5 headings: Background, Objectives, Patients/Methods, Results, and Conclusions.
  • Word count:  3,000 words or less excluding the abstract, references, figures, and tables.
  • Key Words: 5 key words must be provided.

EDITORIAL/COMMENTARY: This category includes commentaries that accompany papers or brief provocative, opinionated communications on a controversial subject. Most commentaries are commissioned, but unsolicited commentaries are also welcome. Unsolicited commentaries will be peer-reviewed. The word count should not exceed 2,000 words excluding the references, figures, and tables.


LETTER: A case presentation written in response to content published previously in Dermatology Practical & Conceptual or a short note reporting on new information not readily available in textbooks for the continuing medical education of dermatologists, dermatopathologists, and general practitioners.

  • Word count: 500 words or less, excluding references, figures, and tables.
  • Abstract: No abstract should be provided.
  • References: 2 references maximum.
  • Subheadings: Introduction, Case Presentation, and Conclusions.

A case report could be submitted as a Letter but must follow these guidelines.


IMAGE LETTER: A case presentation to consist of one image (clinical, dermoscopic, or histopathologic) that represents a “teaching point.” An Image Letter may report on new information not readily available in textbooks for the continuing medical education of dermatologists, dermatopathologists, and general practitioners.

  • Word count: 150 words or less, excluding references, figures.
  • Tables: No tables.
  • Abstract: No abstract.
  • References: 2 references maximum.
  • Subheadings: Case Presentation and Teaching Point.
  • Authors: No more than 4 authors per Image Letter article.

BOOK REVIEW: Books and monographs will be reviewed depending on their interest and value to our readers. Most book reviews are commissioned, but unsolicited reviews are also welcome. Unsolicited book reviews will be reviewed by members of editorial board and may be sent to external reviewers. The word count should not exceed 1,000 words excluding references.

 

Manuscript Guidelines

 

Manuscripts should be submitted in plain English on the Journal’s online Manuscript Management and Submission System. We accept Word or RTF files. Manuscripts should be double-spaced, line-numbered, and page-numbered. copyright agreement and authorship/conflict of interest statement must be submitted with each manuscript. A submitted manuscript is received with the understanding that it is an original contribution not previously published (except as an abstract or preliminary report) and that it is not under consideration for publication elsewhere.

 

FIGURES / IMAGES
Figures must be cited consecutively in the text and numbered in the order in which they are discussed. Legends should be brief and specific and placed on a separate page at the end of the manuscript document.

It is suggested that scale markers within electron micrographic images be used and that  the type of stain used should be indicated.

Photographs and micrographs should be submitted as TIFF or maximum quality JPG files, RGB or grayscale color mode, with a resolution of 300 dpi.

Line art (an image composed of lines and text, which does not contain tonal or shaded areas) should be scanned, if possible, in bitmap mode, 900-1200 dpi, and saved in TIFF format. If the line art file is only available in RGB or grayscale mode, supply at 500-900 dpi and save as maximum quality JPG. Combinations of photographs and line art (an image containing half tone plus text or line art elements) should be submitted in RGB or grayscale color mode, at 500-900 dpi, saved as maximum quality JPG.


REFERENCES

The author(s) are responsible for the accuracy of the references. References must be cited consecutively in the text and be numbered in the order in which they are discussed. Reference numbers appear in brackets before the period in a sentence. A list of references should be provided at the end of each article. If there are more than 6 authors, references should contain the names of the first 3 authors and be followed by et al. Use journal name abbreviations if possible. For abbreviations of journal names, refer to List of Journals Indexed in Index Medicus. This can be accessed at http://www.nlm.nih.gov/tsd/serials/lji.html.

Follow the Journal’s citation style.

Authors: Include up to six authors. If there are more than 6, include the first 3 followed by et al.

Websites: Include the name of the webpage, the name of the entire website, the full date of the page (if available), and the date you looked at it (accessed). Provide the URL that works as close as possible to the date of publication.

Include PMID and/or DOI when available.

Sample References:

Journal article
McKee PH, Fletcher CDM, Rasbridge SA. The enigmatic eccrine epithelioma. Am J Dermatopathol. 1990;12(6):552-561. PMID: 2267993.

Iuliano A, Strianese D, Uccello G, Diplomatico A, Tebaldi S, Bonavolonta G. Risk factors for orbital exenteration in periocular basal cell carcinoma. Am J Ophthmal. 2012;153(2):238–241. PMID: 21982108. DOI: 10.1016/j.ajo.2011.08.004.

Online-only journals; no page numbers; no DOI
Marreiros HF, Loff C, Calado E. Osteoporosis in paediatric patients with spina bifida. J Spinal Cord Med. 2012;35(1):9-21. http://www.ncbi.nlm.nih.gov/pubmed/22330186. Accessed March 28, 2012.

Book chapter
Calonje E, Wilson-Jones E. Vascular tumors. In: Elder D, ed. Lever’s Histopathology of the Skin. 8th ed. Philadelphia: Lippincott; 1997:889-932.

Entire book
Elder D, Elenitsas R. Lever’s Histopathology of the Skin. Philadelphia: Lippincott; 1997.

Software
Epi Info [computer program]. Version 6. Atlanta: Centers for Disease Control and Prevention; 1994.

Database
CANCERNET-PDQ [database online]. Bethesda, MD: National Cancer Institute; 1996. Updated March 29, 1996. Accessed June 26, 1997. Website Gostin LO. Drug use and HIV/AIDS. American Medical Association web site. Available at: http://www.ama-assn.org/special/hiv/ethics. Published June 1, 1996. Accessed June 26, 1997.


TABLES
Tables should be cited consecutively in the text and numbered in that order. Each table should be keyed on a separate sheet, and include the table title, appropriate column heads, and explanatory legends (including definitions of any abbreviations used). Do not embed tables within the body of the manuscript. They should be self-explanatory and should supplement, rather than duplicate, the material in the text.


ABBREVIATIONS AND STYLE

Abbreviations must be defined at first mention in text and in each table and figure. If a brand name is cited, manufacturer and address (city and state/country) should be supplied. For a list of standard abbreviations, consult the Council of Biology Editors Style Guide (available from the Council of Science Editors, 9650 Rockville Pike, Bethesda, MD 20814) or other standard sources. The full term for which an abbreviation stands should precede its first use unless it is a standard unit of measure. Refer to drugs and therapeutic agents by their accepted generic or chemical names, and do not abbreviate the name. Use code numbers only when a generic name is not yet available. In that case, supply the chemical name and a figure giving the chemical structure of the drug. Capitalize the trade names of drugs and place them in parentheses after the generic names. To comply with trademark law, include the name and location (city and state in USA; city and country outside USA) of the manufacturer of any drug, supply, or equipment mentioned in the manuscript. Consult the latest edition the Manual of Style by the American Medical Association for current usage.


PAGE PROOFS
Corresponding authors will be alerted via email when page proofs of copyedited articles are ready. Log into the Journal’s Manuscript Management and Submission System for updates. It is the author’s responsibility to ensure that there are no errors in the proofs. Changes that have been made to make the article conform to Journal style should be allowed to stand if they do not alter the authors’ meaning. Proofs must be checked carefully and returned as requested in the cover letter accompanying the page proofs.


JOURNAL SECTIONS

The following sections are highlighted in the Journal:

  • Allergology
  • Autoimmune & Blistering Diseases
  • Cosmetics & Aesthetic Dermatology
  • Dermatologic Surgery
  • Dermatopathology
  • Hair & Nail Diseases
  • Infectious Diseases & STDs
  • Inflammatory Diseases
  • Oncology (including Dermoscopy, Confocal & Skin Imaging)
  • Pediatric Dermatology

AUTHORSHIP

All primary authors and coauthors listed on the paper must have:

  1. Made significant contribution to the work reported.
  2. Shared responsibility, and accountability for the results of the work, for example, the conception, design, and acquisition of data, analysis, and interpretation.
  3. Shared in drafts or revisions of the paper.
  4. Reviewed and agreed on the final version.
  5. Agreed on the journal to which the paper will be submitted.
  6. Agreed that the corresponding author will be acting on their behalf for any communication about the paper during the submission, peer review process, and after publication.

ACKNOWLEDGEMENTS

All others who contributed to the work who are not authors should be named in the Acknowledgements, and their contribution(s) should be described. All those listed should be aware of it.